Initial Evaluation of Vascudyne Coronary Artery Bypass Conduit
Early Phase 1
- Conditions
- Coronary Artery Disease
- Interventions
- Combination Product: CABA
- First Posted Date
- 2024-05-30
- Last Posted Date
- 2024-06-11
- Lead Sponsor
- Vascudyne, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT06434935
- Locations
- 🇵🇾
Sanatario Italiano, Asunción, Paraguay
Initial Safety Study of the TRUE AVC in Hemodialysis Access (TRUE AVC I Study)
Phase 1
Recruiting
- Conditions
- End Stage Renal Disease
- Interventions
- Biological: Arteriovenous conduit implant
- First Posted Date
- 2022-10-05
- Last Posted Date
- 2022-10-28
- Lead Sponsor
- Vascudyne, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT05567757
- Locations
- 🇵🇦
Centro de Asistencia Renal, RÃo Hato, Coclé, Panama
Preliminary Safety of The TRUE Vascular Graft for Hemodialysis Access (TRUE HD I Study)
Phase 1
Completed
- Conditions
- End Stage Renal Disease
- Interventions
- Biological: natural human collagen arteriovenous graft for hemodialysis access
- First Posted Date
- 2021-05-27
- Last Posted Date
- 2022-06-23
- Lead Sponsor
- Vascudyne, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT04905511
- Locations
- 🇵🇾
Sanatario Italiano, Asunción, Paraguay
© Copyright 2025. All Rights Reserved by MedPath